The neuronal growth-associated protein GAP-43 is expressed maximally during development and regeneration, and is enriched at the cytosolic surface of the growth cone membrane.
GAP-43 can activate the GTP-binding protein G,, which is also a major component of the growth cone membrane. These findings have led to the hypothesis that GAP-43 might modulate neurite outgrowth by altering G-protein activity.
Here we define the sequence requirements for GAP-43 amino terminal peptide stimulation of G,, and test these peptides as potential modulators of neurite outgrowth. The first 10 amino acids of GAP-43, Met-Leu-Cys-Cys-Met-Arg-ArgThr-Lys-Gln, stimulate G,. Substitutions at particular residues reveal that cys3, cys4, arg6, and lys9 are critical, but arg7 is not.
Both the GAP-43( l-10) peptide and the G-protein-activating peptide mastoparan induce growth cone collapse and inhibit neurite extension from embryonic chick dorsal root ganglion and retinal neurons. This is likely to be mediated by G-proteins: pertussis toxin blocks the inhibition, and mutant peptides that do not activate G, do not alter outgrowth. In contrast to the case with embryonic chick dorsal root ganglion cells, neurite outgrowth from NlE-115 neuroblastoma cells is stimulated by . This is probably also a G-protein-mediated event because it is blocked by pertussis toxin, because the sequence requirements match those for G, stimulation, and because mastoparan stimulates outgrowth from these cells. The longer peptide does not alter neurite outgrowth unless the cells are permeabilized, suggesting an intracellular site of action. These data identify a novel set of compounds that modulate neurite outgrowth, and also support the notion that GAP-43 can alter neurite extension by modulating pertussis toxin-sensitive G-protein activity in the growth cone. [Key words: growth-associated protein-43, neuromodulin,
The growth-associated protein GAP-43 (also referred to as neuromodulin, Fl or B50) is a neuronal protein that is enriched on the inner surface of the growth cone membrane, and may be crucial for nerve growth (reviewed in Benowitz and Routtenberg, 1987; Skene, 1989; Strittmatter and Fishman, 199 1) . It is expressed by most, if not all, developing and regenerating neurons during periods of axonal extension. Neurite extension from NGF-stimulated PC 12 cells is enhanced by transfection with a human GAP-43 expression vector (Yankner et al., 1990) . However, GAP-43 is neither necessary nor sufficient for neurite elongation, since PC 12 clones lacking GAP-43 can extend processes (Baetge and Hammang, 199 1) and certain adult neurons express high levels of GAP-43 after axonal elongation ceases (Benowitz et al., 1987) . A modification of the original growth-related thesis is that GAP-43 does not cause axonal extension per se, but rather plays a role in modulating nerve terminal plasticity, perhaps by regulating signal transduction at the membrane . Evidence of the interaction of GAP-43 with transduction machinery includes its ability in vitro to activate certain G-proteins (Strittmatter et al., 1990, 199 l) , to inhibit phosphatidyl-inositol-4-phosphate kinase (Oestricher et al., 1983) and to bind calmodulin (Alexander et al., 1987) . GAP-43 is a substrate for protein kinase C (Coggins and Zwiers, 1989) , and phosphorylation by protein kinase C interferes with calmodulin binding, as do increased calcium levels (Alexander et al., 1987) . Amino acid residues 39-55 constitute the calmodulin-binding domain (Alexander et al., 1988) and the serine at position 41 is the protein kinase C phosphorylation site (Coggins and Zwiers, 1989) .
The pertussis toxin-sensitive G-proteins, G, and G,, are the most prominent noncytoskeletal components of the growth cone membrane (Strittmatter et al., 1990) . Pertussis toxin-sensitive G-proteins have been shown to regulate nerve growth. For example, GDP@ enhances growth of cultured embryonic chick sympathetic neurons . The growth cone collapsing activity of myelin and of embryonic brain membranes is blocked by pertussis toxin (Igarashi et al., 1993) . Expression of activated mutants of the LY subunit of G, increases neurite outgrowth from neuroblastoma and pheochromocytoma cells (Strittmatter et al., 1994a) .
Indirect data led to the hypothesis that GAP-43 alters growth cone motility by activating G-proteins and enhancing their sensitivity to extracellular growth regulators (Strittmatter, 1992) . (Fig. 1) ++ - (Fig. 1) -++ ( Fig. 1 ) + +/- (Fig. 1) ' -- (Strittmatter et al., 1990 ) -- (Sudo et al., 1992 ) -- (Strittmatter et al., 1990) -- (Strittmatter et al., 1990 ) -Purified GAP-43 activates G, and G, (Strittmatter et al., 1990 (Strittmatter et al., , 1991 . It does so by enhancing GDP release, with consequent increase in GTP binding, a mechanism similar to that of G-protein-coupled receptors. In Xenopus oocytes, microinjection of GAP-43 directly stimulates a G-protein cascade (Strittmatter et al., 1993a) . At low concentrations, GAP-43 greatly augments receptor activation of this G-protein-dependent signaling pathway . The ability of GAP-43 transfection to induce morphologic changes in non-neuronal cells (Zuber et al., 1989b ) is dependent on the G-protein-activating domain of the protein (Strittmatter et al., 1994a) and is associated with changes in CAMP levels, which suggest that Gi is activated by GAP-43 expression (Strittmatter et al., 1994b) . Peptides composed of the GAP-43 amino terminal sequence activate G-proteins (Strittmatter et al., 1990; Sudo et al., 1992) , although they are less potent than the intact protein. A peptide composed of the GAP-43 sequences l-10 or 1-25 can activate G, to the same degree as can native GAP-43 (Sudo et al., 1992) .
[The GAP-43( 1 -10) peptide inhibits G, if oxidized, but is stimulatory if stored under reducing conditions.] Replacement of the cysteines in the GAP-43( l-10) peptide by threonine abrogates its stimulatory activity (Strittmatter et al., 1990) , as does palmitoylation (Sudo et al., 1992) , which is a naturally occurring posttranslational modification (Skene and Virag, 1989) . The palmitoylation of these cysteines is required for the membrane association of the GAP-43 protein (Skene and Virag, 1989; Zuber et al., 1989b; Liu et al., 1991) . Because these peptides can be readily synthesized and can substitute for the protein in G, activation assays, we sought to test whether they might affect growth cone physiology. If these peptides were to alter aspects of neuronal growth, they would constitute a novel means to modify growth cone behavior and their action would support the model of G-protein activation by GAP-43 in the growth cone.
Here (Sudo et al., 1992) , and the GAP-43(1-10) peptide inhibited GTPyS binding to G, (Strittmatter et al., 1990) . GTPyS binding to G,. The activation state of G, was monitored by the binding of YS-GTPrS to purified bovine brain G, in a nitrocellulose filtration assay as described in detail previously (Strittmatter et al., 1990, 199 1) . For kinetic assays, tubes with 100 PM GAP-43 peptides and 10 nM G, were prepared on ice, and then assays were initiated by adding 'S-GTPrS to 40 nM and incubating for various times at 23°C before filtration. Initial rates were determined from measurements made during the first l-4 min of incubation at 23°C. In some assays, the G, preparation had been pretreated with pertussis toxin (PTX) in the presence of NAD, as described previously (Strittmatter et al., 1991) . These PTX reaction conditions result in complete ADP-ribosylation of G, (Strittmatter et al., 1991) .
Embryonic dorsal root ganglion cell culture, growth cone collapse, and neurite outgrowth. Dorsal root ganglia were removed from embryonic day 7 chick embryos and explanted onto laminin-coated slides in F12 medium with 5 rig/ml nerve growth factor and 10% fetal calf serum. Peptide solutions or PBS, 1 mM DTT control buffer (50 ~1) was added to explants in culture medium (500 ~1) and the mixture incubated at 37°C for 30 min prior to fixation in 4% paraformaldehyde in PBS. For each explant, all growth cones were then characterized as collapsed or spread as described previously (Igarashi et al., 1993) . In some cases, PTX (100 @ml) was added to the medium 2 hr prior to the addition of the peptide solution.
Dissociated cell cultures were prepared from embryonic DRGs treated with 0.25% trypsin, 1 mM EDTA for 15 min at 37°C. The tissue was then triturated 30 times in growth medium using a fire-polished Pasteur pipette. The material was preplated on untreated plastic for 2 hr to allow non-neuronal cells to attach, and then the free-floating cells were plated onto laminin-coated slides in the presence of '/;O vol ofGAPpeptides or buffer. After 6 hr of culture at 37°C. cells were fixed with 4% naraformaldehyde in PBS, and the fraction of neurons with a process longer than 20 pm was determined.
In some experiments, the DRG neurons were triturated 50 times in medium with or without 50 I.LM GAP-43 peptide just prior to plating, and then the dissociated cells were cultured in the-presence or absence of 10 UM GAP-43 Deotide. This is a modification of the method employed for ~21~~ (Bbrasio et al., 1989 ). (0), or 100 PM l-lOR6 peptide (+). Note that binding is linearly related to time over this period and thai, whereas the l-10 peptide stimulates G,, the l-lOR6 peptide has no effect. This is one of four experiments with similar results. B, Initial rate of 35S-GTPrS binding to-G, in the presence of GAP-43( l-10) peptides. The initial rate of 9-GTPrS binding to G, after 14 min at 23°C was determined in the presence of 100 MM concentrations of the indicated peptides. The wild-tipe l-10 sequence stimulated binding to G,, as described previously (Sudo et al., 1992) . The l-10 R7 mutant was nearly as effective in stimulating G,. In contrast, the l-10 K9 and the l-10 R6 mutant peptides were much less effective stimulators of G,. The values shown are the means f SEM for four separate experiRetinal neuron culture and growth cone collapse. Chick embryonic day 7 temporal retina was cut into small pieces and explanted as described for DRG cultures. Growth cone collapse in the presence of GAP-43( 1 -10) was assayed as described above.
Neuroblastoma~cell culture, neurite outgrowth, and cell permeabilization. N 1 E-115 cells were routinelv cultured in F-12 medium with 10% fetal bovine serum. To induce neuronal differentiation 2% DMSO was added to the medium for a period of 7-10 d. After this treatment, the cells were trypsinized (0.25% trypsin, 5 min, 23°C) and replated onto glass chamber slides precoated sequentially with 0.1 mg/ml poly-Llysine for 1 hr at 23"C, and 10 &ml laminin for 1 hr at 23°C. Onetenth volume of various GAP-43 peptides in PBS, 1 mM DTT or PBS, 1 mM DTT alone was added at the time of plating. After 4 hr of incubation at 37"C, the cells were fixed with PBS, 2% glutaraldehyde, 12% sucrose for 10 min at 23"C, and then stained with Coomassie blue. Consecutive cells in randomly chosen fields were photographed using a video processor and neurite extension was quantitated by an observer unaware ofthe experimental protocol. In some cases, total neurite length for each cell was determined, and in other experiments cells were scored positive if the longest cellular process exceeded one cell diameter.
The permeabilization procedure is identical to that described previously for mouse neuroblastoma cells by Shea et al. (199 1) . Permeabilization is achieved by incubation with 1.2 M glycerol and then 40 pg/ ml phosphatidylcholine at 4°C. GAP-43 peptides were added immediately after the permeabilization and then the cultures were incubated as for nonpermeabilized cells. Statistical analysis. Results were compared by means of a two-tailed Student's t test.
Results

Definition of the G,stimulating domain of GAP-43
We synthesized several variant GAP-43( 1-10) peptides in order to examine the importance of the different amino acids upon G-protein interaction (Table 1) . Because the array of three basic charges in GAP-43 resembles an important component of the G-protein-activating region of G-coupled receptors (Okamoto et al., 1990, 199 la) , we focused upon these residues at positions 6, 7, and 9. There is no stimulation of GTPyS binding to G, with a shorter peptide (l-6), which lacks two of these residues, as reported previously (Sudo et al., 1992) . The first and third basic residues appear to be critical for stimulation of the initial rate of GTPyS binding to G, (Fig. lA,B) . Substitution for the arginine at position 6 (R6) or the lysine at position 9 (K9) markedly reduces the activity when compared to . In contrast, substitution at position 7 (R7) produces little change in G, stimulation, even though the amino acid composition of this peptide is identical to the R6 peptide.
Pertussis toxin (PTX) ADP-ribosylates the a-subunit of G, and prevents activation by receptor-ligand complexes (Gilman, 1987) . PTX pretreatment of G, also diminishes peptide stimulation of GTPrS binding by shifting the EC,, approximately threefold (Fig. 1C ). There is a PTX-insensitive component of G, stimulation above 100 PM peptide, but in the range used for the assays of neurite outgrowth described below, nearly all peptide stimulation of G, is blocked by PTX.
ments. W-GTP+ binding was significantly increased by the 1 -10 and l-lOR7 peptides as compared to the buffer~control (p < -0.01). C, PTX sensitivity of peptide stimulation. 35S-GTPyS binding to purified bovine brain G, was assessed in the presence of the indicated concentrations of GAP-43( l-10) peptide. The G,, preparation had been pretreated with pertussis toxin (PKY, 0) or not pretreated (0) prior to the binding assay. Note that pertussis toxin pretreatment shifts the dose response curve for the GAP-43( 1 -10) peptide stimulation of G, by at least a factor of 3. The values shown are the means L SEM for five separate experiments. At 67 PM GAP-43( 1 -lo), PTX treatment decreased 35S-GTPrS binding significantly (p < 0.05). To assess the reversibility ofgrowth cone collapse, some cultures were incubated with 10 PM GAP-43(1-10) for 1 hr and then the medium was exchanged twice with non-peptide-containing medium. The incubation was continued for the indicated times before fixation and determination of the percentage of collapsed growth cones (0). Note that the percentage of collapsed growth cones returns to control values by 2 hr. The means f SEM from four separate experiments are indicated.
GAP-43 peptides inhibit growth of DRG neurons Dorsal root ganglion (DRG) cell growth cones collapse when exposed to the direct G-protein stimulator mastoparan or to ligands associated with myelin and brain membranes, in a PTXsensitive manner (Igarashi et al., 1993) . The GAP-43( 1-10) peptide also causes growth cone collapse, in a dose-dependent fashion when added to the culture medium (Fig. U,B) . Growth cone collapse occurs by 30-60 min and decays only slightly over 4 hr (Fig. 2C) . The small decrease in growth cone collapse after extended application could be due either to peptide degradation t or to growth cone desensitization. If the peptide-containing growth medium is removed during the period of peak growth cone collapse, neuronal morphology returns to control levels within 2 hr (Fig. 2C) . Thus, the peptide-induced growth cone collapse is a reversible phenomenon. The average number of growth cones per ganglion was not altered by peptide addition (not shown). Pertussis toxin blocks the peptide effect for peptide concentrations up to 30 PM, suggesting that a PTX-sensitive G-protein is directly affected by the peptides or is part ofa signaling cascade stimulated by them (Fig. 2B) . The incomplete blockade at higher peptide concentrations may be due to a PTX-insensitive mechanism of action for the peptide (see Fig. lB ), or to incomplete ADP-ribosylation. The collapsing effect of the mutants and shorter peptides correlates with their G-protein stimulating activity. Thus, the GAP-43( l-6) peptide and the peptide with threonines substituted for the cysteines have no significant collapsing activity (Fig. 3) . Substitution for K9 abrogates collapsing activity, and for R6 significantly reduces activity. The 1-1 OR7 peptide possesses activity intermediate between the wild-type I-10 sequence and the other mutant peptides.
Growth cone collapse has been associated with diminished neurite growth (Raper and Kapfhammer, 1990) . In order to examine peptide effects upon neurite extension, DRG neurons were dissociated and peptides added to the culture medium. After 6 hr, 60% of the cells have regenerated neurites >20 pm in the absence of peptide (Fig. 4) . The GAP-43 amino terminal peptides reduce neurite extension, with a potency 1 -10 > 1 -1 OR7 > l-lOR6. The l-lOK9, l-lOC3C4, and l-6 peptides are not inhibitory. Thus, the potency of the GAP-43( 1-10) peptides in causing both collapse of growth cones and inhibition of neurite outgrowth parallels their potency in stimulating G,. The GAP-43( l-25) peptide causes neither growth cone collapse nor in- 
Effect of GAP-43 amino terminal peptides on other neuronal cell types
To test the generality of the peptide effects we added these reagents to a CNS-derived cell type. The GAP-43( 1-10) peptide induces growth cone collapse in embryonic chick retinal neuron cultures (Fig. 5) . The dose-response curve is nearly identical to that for DRG neurons. N 1 E-l 15 neuroblastoma cells provide an established cell line that can extend neurites after exposure to differentiating agents. Mastoparan, the G-protein-stimulating wasp venom peptide (Higashijima et al., 1988) , stimulates Nl E-l 15 outgrowth in a PTX-sensitive fashion, consistent with G-protein activation increasing Nl E-115 outgrowth (see Fig. 7 ). This is the opposite of its action on DRG neurons (Fig. 4) . Differentiated N 1 E-115 cells exposed to the GAP-43( 1-10) peptide manifest longer neurites than do controls (Fig. 6) . The action of the GAP-43( 1-10) peptide is blocked by PTX, implying that it occurs via G-protein activation (Fig. 7) . As for embryonic DRG neurons, the longer GAP-43( l-25) peptide has no effect (Fig. 6) .
The sequence requirements within the GAP-43 peptide for increasing neurite outgrowth from N 1 E-115 cells exactly match those for stimulating purified G, and for inhibiting DRG outgrowth (Fig. 8) . The l-1 OR7 mutant has slight stimulating activity, but the l-lOR6, l-lOK9, l-lOC3C4, and l-6 peptides are inactive.
GAP-43(1-25) peptide action requires permeabilization
When added to the growth medium, the GAP-43( l-25) peptide does not alter growth cone collapse or neurite outgrowth (Figs.  3, 4, 6 ). This may be due to an intracellular site of action for the shorter GAP-43( 1 -10) peptide and failure of the longer GAP-43( l-25) peptide to gain access to the cell interior. NlE-115 neuroblastoma cells offer an opportunity to examine the necessity for peptide entry into the cell, because effective methods have been devised for the permeabilization of these cells (Shea et al., 199 1) . Permeabilization of N 1 E-115 cells by phospholipid and glycerol prior to addition of the GAP-43( l-25) peptide allows the longer peptide to stimulate neurite extension (Figs. 9, 10). After permeabilization, the GAP-43( l-25) peptide stimulates neurite outgrowth to the same degree as does the l-10 peptide. This suggests that the GAP-43( l-25) peptide does not have access to the cytosol of unpermeabilized cells, and that its site of action in permeabilized cells is intracellular. In contrast, the mutated GAP-43( l-10) peptides, which do not stimulate G,,, remain inactive after permeabilization (Fig. 10) . Their inactivity is therefore unlikely to be secondary to decreased access to the cytosol. The potency of the l-10 peptide is increased about fivefold by cell permeabilization (Fig. 1 l) , suggesting that GAP-43( 1-10) has partial access to an intracellular site of action and that this can be increased by permeabilization. We utilized a different method to permeabilize dissociated DRG neurons. Trituration has been shown to disrupt the membrane bilayer mechanically and allow entry of proteins into the cell (Borasio et al., 1989) . Trituration of DRG cells with buffer prior to plating does not significantly alter neurite outgrowth during the first 4 hours in culture (Fig. 12) caused by bath application of the GAP-43(1-10) peptide. Cell viability, as determined by trypan blue staining, is 85-90% after trituration with buffer, GAP-43( 1-10) or . Thus, the peptides do not affect cell survival, even after trituration. We tested peptides from two other regions of GAP-43 for their effect on DRG and N 1 E-115 neurite outgrowth. Peptides from residues 53-69(A) and 210-226(B) do not stimulate G, (Strittmatter et al., 1990) . These peptides have no effect on neurite outgrowth even in permeabilized cells (Figs. 8, 10, 12 ).
Discussion
GAP-43(1-IO) peptide alters G-protein activity and neurite outgrowth
We show here that peptides composed of the GAP-43 amino terminus can affect neurite length and growth cone collapse. Different cells are affected differently. The GAP-43( 1 -10) peptide causes collapse of DRG and retinal growth cones, and diminishes neurite length; the same peptide enhances neurite extension from neuroblastoma cells. Several experiments indicate that these effects are mediated by G-protein stimulation. The wasp venom peptide mastoparan, a known G,/G, stimulator (Higashijima et al., 1988) , affects these two cell types in the same manner as does the GAP-43( 1 -10) peptide. Pertussis toxin ADP-ribosylates GJG, (Gilman, 1987) and blocks the action of the GAP-43( l-10) peptide as a G, stimulator and as a regulator of neuronal growth. Furthermore, the order of potency of the peptides upon neurite growth (whether stimulatory or inhibitory, depending on the cell) parallels the order of potency of the peptides as G, stimulators.
There are several explanations for the effects of G protein activation varying among cell types. In contrast to DRG and retinal neurons, NlE-115 cells might have a different complement of G-proteins subject to mastoparan and GAP-43( l-10) activation, or the same G-protein might interact with a different second messenger system, or the same second messenger system might have a different effect on neurite outgrowth.
It is not unexpected that reagents which alter G-protein ac- tivity might modulate neurite outgrowth. The nonhydrolyzable guanine nucleotide analog GTP-yS stimulates G-proteins and decreases sympathetic neuron outgrowth; GDP@S inhibits G-protein activation and stimulates outgrowth (Strittmatter et al., 1992) . Expression of activated mutants of the (Y subunit of G, promote neurite outgrowth (Strittmatter et al., 1994a) . Furthermore, ligands for G-protein-coupled receptors such as serotonin, dopamine, and thrombin induce growth cone collapse in particular cell types (Haydon et al., 1984; Lankford et al., 1988; Rodrigues and Dowling, 1990; Suidan et al., 1992) . The neurite outgrowth modulating activity of both membrane-bound growth cone collapsing factors (Igarashi et al., 1993) and cell adhesion molecules (Doherty et al., 199 1) can be abrogated by pertussis toxin treatment of neurons.
GAP-43 amino-terminal peptides appear to act intracellularly GAP-43 amino-terminal peptides must gain entry into the cell if they are to act directly on intracellular G-proteins. The GAP-43( l-25) peptide data provide the strongest support for the notion that the GAP-43 peptides act intracellularly. The longer peptide can stimulate G, in vitro, but does not alter neurite outgrowth unless the cell is permeabilized. The GAP-43( l-10) peptide can affect both DRG and N 1 E-115 cell neurite extension without prior cell permeabilization, but its potency is increased by permeabilization. It is not clear by what route the 1-10 peptides gain entry into the cell. Disruption of neurites during dissection of DRG or retinal neurons, or during replating of Nl El 15 cells certainly might cause temporary breaches in the plasma membrane. For example, trituration allows the neuronal entry of small protein molecules, such as p2 1 ras and related proteins (Borasio et al., 1989; Ayala et al., 1990) . It is also possible that the shorter peptides can cross the intact membrane. An Antennapedia homeobox polypeptide of 60 amino acid residues can enter motoneurons (Bloch-Gallego et al., 1993) and mastoparan is thought to cross the plasma membrane directly (Higashijima et al., 1988) . We could not demonstrate this unequivocally for the GAP-43 peptides without creating radiolabeled active peptides, or isolating antibodies that distinguish peptides from native protein.
For several reasons, it is unlikely that mutant l-10 peptides are inactive due to decreased access to the cytosol. First, the sequence requirements for neurite regulation match those for Figure 7 . The stimulatory effect of GAP-43( l-10) peptide and mastoparan on neuroblastoma cell outgrowth is blocked by pertussis toxin. Cultures were incubated with buffer (P&S), 120 PM GAP-43( 1 -lo), peptide or mastoparan (MP) as described in Figure 4 . Some cultures were pretreated for 2 hr with 200 rig/ml pertussis toxin (PTX) and pertussis toxin was included in the peptide incubation for these samples. Note that the GAP-43( 1 -10) peptide and mastoparan both increase the fraction of cells with a neurite greater than 1 cell diameter in length and that this effect is blocked by pertussis toxin pretreatment. The values shown are the means +SEM for four separate determinations. **, significantly different from PBS, p < 0.0 1.
Second, the pertneabilization procedure that allows entry of the 1-25 peptide does not promote the activity of the 1-lOR6 or l-lOK9 peptides. Third, the I-lOR6 and 1-1 OK9 are less charged than the 1-10 peptide so that their crossing of a lipid bilayer presents a lower energy barrier.
GAP-43 amino-terminal sequence requirements
In designing these growth-modulating peptides, we focused upon alterations of the basic amino acid residues because peptide studies of the G-protein-activating regions of receptors suggested that an array of basic charges, B-B-X-B or B-B-X-X-B, is critical for stimulation (Okamoto et al., 1990 (Okamoto et al., , 1991a , and this region of GAP-43 includes the sequence Arg6-Arg7-Thr8-Lys9. The activating domains in receptors differ from the amino terminus of GAP-43 by their inclusion of additional basic charges amino terminal to this canonical stretch. The order of potency of peptides, for both G, stimulation and effect upon neurite outgrowth, is I-10 = l-lOR7 > I-lOR6 = l-lOK9. Interestingly, G-protein stimulation by peptides derived from receptors also is reduced to a greater degree by mutating the first or third basic amino acid of the B-B-X-B sequence than by mutating the second (Okamoto et al., 1991 b) . While this approach to choosing amino acids to mutate was useful in designing the GAP-43 peptides, the stretch of similarity to the receptor is so short that it could be fortuitous. Nonetheless, the sensitivity of GAP-43( 1 -10) peptide action to PTX implies some similarity between GAP-43( l-10) peptide and receptor activation of G-proteins.
The other GAP-43 amino acid residues critical to G-protein stimulation are cys3 and cys4. In the intact protein, these are subject to palmitoylation, which enhances membrane binding (Skene and Virag, 1989; Zuber et al., 1989; Liu et al., 199 1) and diminishes G, activation (Sudo et al., 1992) . Their palmitoylation in the GAP-43( l-25) peptide also blocks its Go-activating ability (Sudo et al., 1992) . Threonine substitution for the cys- teines abrogates Go-activating capability (Strittmatter et al., 1990) , and blocks the peptide effect upon neurite growth.
Relationship to endogenous GAP-43 protein
For the reasons described above, the GAP-43 amino-terminal peptides are likely to act by stimulating an intracellular PTXsensitive G-protein. In vitro, both the protein and the peptide stimulate G,, and appear to do so through a single site, with the protein being about 40-fold more potent (Strittmatter et al., 1990) . Does endogenous GAP-43 protein act by this mechanism in vivo? The ability of GAP-43 to regulate G-protein-based signal transduction when injected in Xenopus oocytes and when transfected into non-neuronal cells (Strittmatter et al., 1994a) supports the hypothesis that endogenous GAP-43 protein modulates G-protein activation.
The 5-l 00 PM concentration at which the 1 -10 peptide has a graded effect on neurite outgrowth would have Go-stimulating activity equivalent to 0.1-2.5 PM nonpalmitoylated, endogenous GAP-43 protein (Strittmatter et al., 1990) . Since the total concentration of GAP-43 protein is about 2 PM in whole brain and 5-20% is in the free-sulfhydryl, nonpalmitoylated form (Skene and Virag, 1989) , physiologic concentrations of GAP-43 are predicted to be roughly equivalent to those of the 1 -10 peptide. This is a crude estimate of the relative efficacy of the l-10 peptide versus the endogenous protein because we cannot precisely measure intracellular peptide concentration, peptide palmitoylation levels (if any), or the degree of intracellular sequestration of GAP-43 protein and/or peptide from G-protein.
GAP-43 protein is likely to have effects not shared by the peptide since the protein can bind calmodulin (Alexander et al., 1987) , be phosphorylated by protein kinase C (Coggins and Zwiers, 36  68  96  126  158  Neurite  length  (,u per cell) 1989), and bind to actin filaments . Clearly, the simplest extrapolation from the data here is that one of the actions of endogenous GAP-43 protein is similar to that of the peptide. The stimulation of G, and the regulation of neurite outgrowth by GAP-43( 1 -10) is mildly sensitive to PTX, exhibiting blockade at low concentrations of peptide, but not at high concentrations. Our previous observation that G, stimulation by 1 MM GAP-43 is not blocked by PTX (Strittmatter et al., 199 1) might be due to a different mechanism of action for the peptide and the protein. More likely, these differences can be attributed to the use of GAP-43 concentrations above saturation in the previous study, or to a greater PTX sensitivity for peptide as compared to protein action at one site resulting in G, stimulation.
Growth cone signal amplijication
Many receptor proteins which act via G-proteins have been identified, and some are known to be present in the growth cone and to induce growth cone collapse. When injected into Xenopus oocytes, GAP-43 not only directly activates a G-protein cascade, but also sensitizes the cell to ligands for G-protein-coupled receptors . By analogy, exogenous GAP-43 peptide and/or endogenous GAP-43 protein might increase the "gain" of a growth cone signal transduction system for ligands in the extracellular environment. Such ligands might either stimulate or inhibit neurite extension. During development and regeneration, signal amplification is critical, since the contact of a single filopodium with appropriate pathways or targets can redirect the entire growth cone (Kapfiammer and Raper, 1987) .
Whether or not these peptides act at molecular sites identical to the native protein, they represent a novel class of neurite outgrowth modulating compounds. It will be of interest to test their effects on nerve regeneration in whole animals because they might lead to a class of therapeutic agents to modify nervous system development, plasticity, and regeneration. The percentage of differentiated N 1 E-115 cells which had extended a neurite greater than one cell diameter was determined after incubation in the presence of the indicated concentrations of the GAP-43( 1-10) peptide. Cells were either permeabilized (0) or not permeabilized (0) at the time of peptide addition. Note that for unpermeabilized cells 30-100 FM peptide is required to stimulate outgrowth, but that for permeabilized cells as little as 4 PM peptide increased outgrowth significantly above buffer control levels (p < 0.0 1). The values were normalized for the percentage of cells with neurites > cell diameter in the absence of peptide, which was 121 for the permeabilized cells and 24% for the unpermeabilized cells. The mean values ?SEM for two to five determinations are illustrated. . inhibits neurite outgrowth when triturated with DRG neurons. DRG neurons were triturated in the presence of buffer or 50 PM GAP-43 peptides, and then dissociated cells were plated in the presence of buffer or 10 PM GAP-43 peptides. The PBS samples were never exposed to peptide. GAP-43 peptides were added before trituration (left) or after trituration (right) . Four hours after plating the percentage of cells with neurites longer than 20 pm was determined. Note that the GAP-43( l-25) peptide inhibits outgrowth only when present during trituration. The values shown are the means +SEM for five separate experiments. **, significantly different from PBS, p < 0.0 1.
